215 related articles for article (PubMed ID: 27807729)
1. Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis.
Karakousis G; Gimotty PA; Bartlett EK; Sim MS; Neuwirth MG; Fraker D; Czerniecki BJ; Faries MB
Ann Surg Oncol; 2017 Apr; 24(4):952-959. PubMed ID: 27807729
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup.
Ribero S; Osella-Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P
Ann Surg Oncol; 2016 May; 23(5):1708-15. PubMed ID: 26597362
[TBL] [Abstract][Full Text] [Related]
4. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
[TBL] [Abstract][Full Text] [Related]
5. Exhaustive pathologic work-up in sentinel lymph node biopsy for melanoma: is it necessary?
Lino-Silva LS; Castillo-Medina AL; Salcedo-Hernández RA; García-Pérez L
Melanoma Res; 2017 Apr; 27(2):116-120. PubMed ID: 28030434
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
7. Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation.
Fahy AS; Grotz TE; Keeney GL; Glasgow AE; Habermann EB; Erickson L; Hieken TJ; Jakub JW
J Surg Oncol; 2016 Dec; 114(7):879-883. PubMed ID: 27634587
[TBL] [Abstract][Full Text] [Related]
8. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
; Crystal JS; Thompson JF; Hyngstrom J; Caracò C; Zager JS; Jahkola T; Bowles TL; Pennacchioli E; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; van Akkooi A; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Neves RI; Rossi CR; Kane JM; Trocha S; Wright F; Byrd DR; Matter M; Hsueh EC; MacKenzie-Ross A; Kelley M; Terheyden P; Huston TL; Wayne JD; Neuman H; Smithers BM; Ariyan CE; Desai D; Gershenwald JE; Schneebaum S; Gesierich A; Jacobs LK; Lewis JM; McMasters KM; O'Donoghue C; van der Westhuizen A; Sardi A; Barth R; Barone R; McKinnon JG; Slingluff CL; Farma JM; Schultz E; Scheri RP; Vidal-Sicart S; Molina M; Testori AAE; Foshag LJ; Van Kreuningen L; Wang HJ; Sim MS; Scolyer RA; Elashoff DE; Cochran AJ; Faries MB
JAMA Surg; 2022 Sep; 157(9):835-842. PubMed ID: 35921122
[TBL] [Abstract][Full Text] [Related]
10. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
[TBL] [Abstract][Full Text] [Related]
14. Association of sentinel lymph node diameter with melanoma metastasis.
Merkow J; Paniccia A; Jones E; Jones T; Hodges M; Stovall R; Kounalakis N; Gajdos C; Lewis K; Robinson W; Gonzalez R; Pearlman N; McCarter M
Am J Surg; 2016 Aug; 212(2):315-20. PubMed ID: 26827186
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I).
Cochran AJ; Wen DR; Huang RR; Abrishami P; Smart C; Binder S; Scolyer RA; Thompson JF; Stern S; Van Kreuningen L; Elashoff DE; Sim MS; Wang HJ; Faries MB;
Eur J Surg Oncol; 2022 Jun; 48(6):1280-1287. PubMed ID: 35246348
[TBL] [Abstract][Full Text] [Related]
16. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
Karakousis GC; Gimotty PA; Czerniecki BJ; Elder DE; Elenitsas R; Ming ME; Fraker DL; Guerry D; Spitz FR
Ann Surg Oncol; 2007 May; 14(5):1596-603. PubMed ID: 17285396
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Adoption and Outcomes of Nodal Observation for Patients with Melanoma and Sentinel Lymph Node Metastases.
Parvez E; Khosrow-Khavar F; Dumitra T; Nessim C; Bernard-Bédard É; Rivard J; Pravong V; Wang S; Gervais MK; Meterissian S; Dumitra S
Ann Surg Oncol; 2023 Feb; 30(2):1195-1205. PubMed ID: 36282456
[TBL] [Abstract][Full Text] [Related]
18. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
19. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
Pavri SN; Han G; Khan S; Han D
J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
[TBL] [Abstract][Full Text] [Related]
20. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]